Cargando…

Surgical Resection of Primary Tumors Provides Survival Benefits for Lung Cancer Patients With Unexpected Pleural Dissemination

Background: Surgery is not generally recommended for non-small cell lung cancer (NSCLC) patients with malignant pleural dissemination (PD). However, in some cases, PD is found unexpectedly during surgery. There is no consensus on whether surgical intervention can provide survival benefit for them. W...

Descripción completa

Detalles Bibliográficos
Autores principales: Fan, Liwen, Yang, Haitang, Han, Ke, Zhao, Yang, Gao, Wen, Schmid, Ralph A., Yao, Feng, Zhao, Heng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8260680/
https://www.ncbi.nlm.nih.gov/pubmed/34250008
http://dx.doi.org/10.3389/fsurg.2021.679565
_version_ 1783718857059336192
author Fan, Liwen
Yang, Haitang
Han, Ke
Zhao, Yang
Gao, Wen
Schmid, Ralph A.
Yao, Feng
Zhao, Heng
author_facet Fan, Liwen
Yang, Haitang
Han, Ke
Zhao, Yang
Gao, Wen
Schmid, Ralph A.
Yao, Feng
Zhao, Heng
author_sort Fan, Liwen
collection PubMed
description Background: Surgery is not generally recommended for non-small cell lung cancer (NSCLC) patients with malignant pleural dissemination (PD). However, in some cases, PD is found unexpectedly during surgery. There is no consensus on whether surgical intervention can provide survival benefit for them. We investigated the role of surgery in NSCLC patients with unexpected PD by a cohort study. Methods: Clinical data of consecutive patients who intended to undergo radical surgery for NSCLC between January 2010 and December 2015 at Shanghai Chest Hospital and Huadong Hospital were collected from a lung cancer database. Patients diagnosed with unexpected malignant pleural nodules intraoperatively were enrolled in this retrospective study. Results: A total of 181 NSCLC patients were diagnosed with unexpected malignant PD intraoperatively and confirmed with postoperatively histological examinations. Out of these, 80 (44.2%) patients received pleural nodule biopsies alone, and 101 (55.8%) received primary tumor resection (47 with sublobar resection and 54 with lobectomy). The median progression-free survival and overall survival for all patients were 13 and 41 months respectively. Patients in the resection group had significantly better progression-free survival (19.0 vs. 10.0 months, P < 0.0001) and overall survival (48.0 vs. 33.0 months, P < 0.0001) than patients in the biopsy group. In the resection group, there was no statistical difference between patients with sublobar resection and lobectomy (P = 0.34). Univariate and multivariate analyses identified primary tumor resection, targeted adjuvant therapy, and tumor size (≤ 3 cm) as independent prognostic factors. Conclusions: NSCLC patients with unexpected intraoperative PD potentially benefited from surgical resection of the primary tumor and multidisciplinary targeted therapy, particularly when tumor size did not exceed 3 cm. Our data demonstrated that the resection type was not associated with survival differences, which remains to be defined with a larger sample size.
format Online
Article
Text
id pubmed-8260680
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-82606802021-07-08 Surgical Resection of Primary Tumors Provides Survival Benefits for Lung Cancer Patients With Unexpected Pleural Dissemination Fan, Liwen Yang, Haitang Han, Ke Zhao, Yang Gao, Wen Schmid, Ralph A. Yao, Feng Zhao, Heng Front Surg Surgery Background: Surgery is not generally recommended for non-small cell lung cancer (NSCLC) patients with malignant pleural dissemination (PD). However, in some cases, PD is found unexpectedly during surgery. There is no consensus on whether surgical intervention can provide survival benefit for them. We investigated the role of surgery in NSCLC patients with unexpected PD by a cohort study. Methods: Clinical data of consecutive patients who intended to undergo radical surgery for NSCLC between January 2010 and December 2015 at Shanghai Chest Hospital and Huadong Hospital were collected from a lung cancer database. Patients diagnosed with unexpected malignant pleural nodules intraoperatively were enrolled in this retrospective study. Results: A total of 181 NSCLC patients were diagnosed with unexpected malignant PD intraoperatively and confirmed with postoperatively histological examinations. Out of these, 80 (44.2%) patients received pleural nodule biopsies alone, and 101 (55.8%) received primary tumor resection (47 with sublobar resection and 54 with lobectomy). The median progression-free survival and overall survival for all patients were 13 and 41 months respectively. Patients in the resection group had significantly better progression-free survival (19.0 vs. 10.0 months, P < 0.0001) and overall survival (48.0 vs. 33.0 months, P < 0.0001) than patients in the biopsy group. In the resection group, there was no statistical difference between patients with sublobar resection and lobectomy (P = 0.34). Univariate and multivariate analyses identified primary tumor resection, targeted adjuvant therapy, and tumor size (≤ 3 cm) as independent prognostic factors. Conclusions: NSCLC patients with unexpected intraoperative PD potentially benefited from surgical resection of the primary tumor and multidisciplinary targeted therapy, particularly when tumor size did not exceed 3 cm. Our data demonstrated that the resection type was not associated with survival differences, which remains to be defined with a larger sample size. Frontiers Media S.A. 2021-06-23 /pmc/articles/PMC8260680/ /pubmed/34250008 http://dx.doi.org/10.3389/fsurg.2021.679565 Text en Copyright © 2021 Fan, Yang, Han, Zhao, Gao, Schmid, Yao and Zhao. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Surgery
Fan, Liwen
Yang, Haitang
Han, Ke
Zhao, Yang
Gao, Wen
Schmid, Ralph A.
Yao, Feng
Zhao, Heng
Surgical Resection of Primary Tumors Provides Survival Benefits for Lung Cancer Patients With Unexpected Pleural Dissemination
title Surgical Resection of Primary Tumors Provides Survival Benefits for Lung Cancer Patients With Unexpected Pleural Dissemination
title_full Surgical Resection of Primary Tumors Provides Survival Benefits for Lung Cancer Patients With Unexpected Pleural Dissemination
title_fullStr Surgical Resection of Primary Tumors Provides Survival Benefits for Lung Cancer Patients With Unexpected Pleural Dissemination
title_full_unstemmed Surgical Resection of Primary Tumors Provides Survival Benefits for Lung Cancer Patients With Unexpected Pleural Dissemination
title_short Surgical Resection of Primary Tumors Provides Survival Benefits for Lung Cancer Patients With Unexpected Pleural Dissemination
title_sort surgical resection of primary tumors provides survival benefits for lung cancer patients with unexpected pleural dissemination
topic Surgery
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8260680/
https://www.ncbi.nlm.nih.gov/pubmed/34250008
http://dx.doi.org/10.3389/fsurg.2021.679565
work_keys_str_mv AT fanliwen surgicalresectionofprimarytumorsprovidessurvivalbenefitsforlungcancerpatientswithunexpectedpleuraldissemination
AT yanghaitang surgicalresectionofprimarytumorsprovidessurvivalbenefitsforlungcancerpatientswithunexpectedpleuraldissemination
AT hanke surgicalresectionofprimarytumorsprovidessurvivalbenefitsforlungcancerpatientswithunexpectedpleuraldissemination
AT zhaoyang surgicalresectionofprimarytumorsprovidessurvivalbenefitsforlungcancerpatientswithunexpectedpleuraldissemination
AT gaowen surgicalresectionofprimarytumorsprovidessurvivalbenefitsforlungcancerpatientswithunexpectedpleuraldissemination
AT schmidralpha surgicalresectionofprimarytumorsprovidessurvivalbenefitsforlungcancerpatientswithunexpectedpleuraldissemination
AT yaofeng surgicalresectionofprimarytumorsprovidessurvivalbenefitsforlungcancerpatientswithunexpectedpleuraldissemination
AT zhaoheng surgicalresectionofprimarytumorsprovidessurvivalbenefitsforlungcancerpatientswithunexpectedpleuraldissemination